Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

GENCOR
Gencor Industries receives NYSE filing delinquency notice for late Q1 10-Q

Gencor Industries received a delinquency notification from NYSE Regulation on May 19, 2026 for failing to timely file its Form 10-Q for the quarter en...

Hewlett
HPE reports record Q2 FY2026 revenue of $10.7B, raises full-year guidance

Hewlett Packard Enterprise delivered record-breaking revenue, profitability, and free cash flow in Q2, driven by strong demand for AI infrastructure a...

Credo
Credo Technology reports FY2026 revenue of $1.3B, triples YoY; guides Q1 FY2027 revenue $465-475M

Credo Technology reported fourth quarter fiscal 2026 revenue of $437.0 million, up 157% year-over-year, with full-year revenue tripling to $1.3 billio...

Samsara
Samsara Inc. converts from Delaware to Nevada corporation effective April 28, 2026

Samsara Inc. has adopted a plan of conversion to reincorporate from a Delaware corporation to a Nevada corporation while maintaining the same name and...

GRAIL,
GRAIL promotes Joshua Ofman to Chief Executive Officer effective June 1, 2026

Joshua Ofman has been promoted to CEO of GRAIL, Inc. with an $800,000 annual base salary and Board seat. The leadership transition reflects the compan...

Liberty
Liberty Global names Stephen van Rooyen as Ziggo Group CEO ahead of 2027 listing

Liberty Global appointed VodafoneZiggo CEO Stephen van Rooyen as Chief Executive Officer of newly-formed Ziggo Group, combining Dutch and Belgian tele...

PRINCIPAL
Principal Financial Group issues $400M senior notes due 2037 at 5.3%

Principal Financial Group completed an underwriting agreement to issue $400 million in 5.300% senior notes due 2037, with BofA Securities, Goldman Sac...

Industrial
Industrial Logistics Properties Trust releases June 2026 investor presentation

ILPT presented an investor update highlighting its portfolio including a 1,015,740 sq ft property in Spartanburg, SC with 100% ILPT ownership. The pre...

IDEAYA
IDEAYA's darovasertib plus crizotinib shows efficacy in HLA-A2 negative uveal melanoma

IDEAYA Biosciences announced primary results from the OptimUM-02 trial evaluating darovasertib combined with crizotinib as first-line treatment for HL...

AH
AH Realty Trust presents Q1 2026 investor deck with deleveraging and share repurchase plans

AH Realty Trust unveiled a simplified REIT platform focused on high-quality open-air retail and mixed-use office properties in strong secondary market...

aTYR
aTyr Pharma presents clinical development program for efzofitimod in pulmonary sarcoidosis.

aTyr Pharma released an investor presentation outlining advancement of efzofitimod, its tRNA synthetase-derived therapeutic candidate, for pulmonary s...

DIVERSIFIED
Diversified Healthcare Trust presents June 2026 investor guidance and strategic outlook

DHC issued forward-looking guidance for 2026 including NOI, Normalized FFO and capital expenditure expectations. The company outlined strategic initia...

NEW
NJNG files with NJBPU for 8.9% customer bill reduction and $950M rate recovery

New Jersey Natural Gas submitted filings providing 8.9% bill savings ($158 annually per residential customer) for winter 2026-2027 while seeking base ...

Dime
Dime Community Bancshares changes corporate name to Dime Commercial Bancshares

The company amended its certificate of incorporation to change its name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effe...

PSQ
PSQ Holdings terminates Michael Hebert; provides $137,500 severance package

PSQ Holdings Inc. entered into a severance agreement with Michael Hebert, providing six months' pay ($137,500) and COBRA premium subsidies through Dec...

Keros
Keros Therapeutics CEO to speak at Goldman Sachs healthcare conference

Keros Therapeutics President and CEO Jasbir Seehra will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference o...

Spectral
Spectral AI receives FDA De Novo clearance for DeepView burn diagnostic system

Spectral AI announced FDA De Novo Classification for its DeepView System for burn wound assessment, authorizing commercial distribution in the U.S. Th...

Spyre
Spyre Therapeutics amends license agreement with Paragon Therapeutics expanding field of use.

Spyre and Paragon amended their license agreement dated February 2025 to expand the Field definition from inflammatory bowel disease to all therapeuti...

Oruka
Oruka amends IL-23 license agreement with Paragon expanding field to all therapeutic areas

Oruka Therapeutics and Paragon Therapeutics executed a first amendment to their IL-23 license agreement dated May 29, 2026, expanding the Field defini...

Epsilon
Epsilon Energy declares $0.0625 quarterly dividend and raises borrowing base to $90M

Epsilon Energy Ltd. announced a quarterly dividend of $0.0625 per share (annualized $0.25/sh) payable June 30, 2026, and completed a borrowing base re...